FOSTER CITY, Calif. & HOUSTON--(BUSINESS WIRE)--Oct. 26, 2005--Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and VisiGen Biotechnologies, Inc., announced today that Applied Biosystems has signed a definitive agreement to make an equity investment in privately held VisiGen, a next-generation sequencing technology company, and to enter into a scientific collaboration agreement with VisiGen concurrent with the closing of the investment. The investment and the collaboration are subject to closing conditions specified in the investment agreement, including VisiGen’s receipt of an additional investment from SeqWright, Inc., an existing VisiGen shareholder, and other conditions that are customary for a transaction of this type. The companies expect that Applied Biosystems’ investment will be made and the collaboration commenced by calendar year end. Financial terms of the transactions were not disclosed.
